Hepatocellular Carcinoma

• CLINICAL_TRIALS research · 2018-04-30
  Clinical Trial Update: The Study of The Treatment of Postoperative Adjuvant Apatinib vs. TACE in Hepatocellular Carcinoma Patients [Phase 2]

  Phase 2 clinical trial comparing postoperative adjuvant apatinib to transarterial chemoembolization in hepatocellular carcinoma patients. St…

• CLINICAL_TRIALS trial_result · 2018-04-27
  Clinical Trial Update: Efficacy and Safety of Apatinib Combined With TACE in Patients With Hepatocellular Carcinoma [Phase 2]

  Phase 2 clinical trial evaluating the efficacy and safety of combining apatinib with transarterial chemoembolization (TACE) in hepatocellula…

• CLINICAL_TRIALS trial_result · 2018-04-26
  Clinical Trial Update: Contrast (Sonazoid)-Enhanced US as a Screening Tool for Hepatocellular Carcinoma in Cirrhosis: An Exploratory Cross-sectional Study [NA]

  An exploratory cross-sectional study completed at Yonsei University evaluated contrast-enhanced ultrasound using Sonazoid to screen for hepa…

• CLINICAL_TRIALS trial_result · 2018-04-25
  Clinical Trial Update: A Pilot Study of Optical Molecular Imaging for Percutaneous Biopsy of Hepatocellular Carcinoma Using Indocyanine Green [EARLY_Phase 1]

  Update on an early-phase pilot trial evaluating optical molecular imaging with indocyanine green to guide percutaneous biopsy of hepatocellu…

• CLINICAL_TRIALS trial_result · 2018-04-25
  Clinical Trial Update: STA-9090 in Patients With Advanced Hepatocellular Cancer [Phase 1]

  A Phase 1 trial evaluating STA-9090 for advanced hepatocellular carcinoma has completed.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2018-04-25
  Clinical Trial Update: TACE for HCC by TANDEM and Idarubicin

  A clinical trial evaluating transarterial chemoembolization for hepatocellular carcinoma using the TANDEM approach with idarubicin has compl…

• CLINICAL_TRIALS trial_result · 2018-04-24
  Clinical Trial Update: Study to Compare Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma (HCC) [Phase 3]

  This document describes a Phase 3 clinical trial comparing selective internal radiation therapy (SIRT) with Sorafenib in locally advanced he…

• CLINICAL_TRIALS research · 2018-04-20
  Clinical Trial Update: A New Prognostic Scoring System for Spontaneous Ruptured Hepatocellular

  Completed trial update describing a novel prognostic scoring system for spontaneous rupture of hepatocellular carcinoma.

• CLINICAL_TRIALS trial_result · 2018-04-19
  Clinical Trial Update: Impact of Three-dimensional Visualization on Operation Strategy and Complications for Complex Hepatic Carcinoma

  This clinical trial explores whether three-dimensional visualization enhances surgical planning and reduces complications in complex hepatoc…

• CLINICAL_TRIALS withdrawal · 2018-04-19
  Clinical Trial Update: Combination Treatment for Advanced Liver Cancer [Phase 3]

  A Phase 3 clinical trial evaluating a combination therapy for advanced hepatocellular carcinoma, including cases with hepatic portal vein tu…

• CLINICAL_TRIALS research · 2018-04-17
  Clinical Trial Update: Phase 1b of ASLAN001 (Varlitinib) in Patients With Advanced/ Metastatic Hepatocellular Carcinoma (HCC) [Phase 1, Phase 2]

  A Phase 1b/Phase 2 clinical trial evaluating varlitinib (ASLAN001) in advanced or metastatic hepatocellular carcinoma is ongoing, with curre…

• CLINICAL_TRIALS research · 2018-04-13
  Clinical Trial Update: Resection Versus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma With Solitary Huge Tumor [NA]

  Update on a clinical trial comparing surgical resection versus transcatheter arterial chemoembolization for hepatocellular carcinoma with a …

• CLINICAL_TRIALS research · 2018-04-12
  Clinical Trial Update: Feasibility of High Dose PROton Therapy On Unresectable Primary Carcinoma Of Liver: Prospective Phase II Trial [Phase 2]

  A prospective Phase II study evaluating high-dose proton therapy for unresectable primary liver cancer (hepatocellular carcinoma).

• CLINICAL_TRIALS research · 2018-04-10
  Clinical Trial Update: Study on Recurrence Monitoring of Hepatocellular Carcinoma With 5-Hydroxymethylcytosine Test

  Clinical trial update investigating recurrence monitoring of hepatocellular carcinoma using a 5-Hydroxymethylcytosine biomarker test.

• CLINICAL_TRIALS trial_result · 2018-04-06
  Clinical Trial Update: Effects of Statin on Hepatocellular Carcinoma Recurrence After Liver Transplantation

  A completed study assessing whether statin therapy influences recurrence of hepatocellular carcinoma after liver transplantation. The update…

• CLINICAL_TRIALS trial_result · 2018-04-02
  Clinical Trial Update: Study of Oral Ceritinib in Patients With ALK and ROS1 Activated Gastrointestinal Malignancies [Phase 2]

  A Phase 2 study evaluating ceritinib in ALK- and ROS1-activated gastrointestinal cancers has been terminated.

• CLINICAL_TRIALS trial_result · 2018-03-29
  Clinical Trial Update: A Randomized, Controlled Phase III Trial of Sorafenib With or Without cTACE in Patients With Advanced HCC [Phase 3]

  A Phase III randomized trial assessed adding conventional transarterial chemoembolization (cTACE) to sorafenib versus sorafenib alone in adv…

• CLINICAL_TRIALS trial_result · 2018-03-26
  Clinical Trial Update: R1vascular Hepatectomy for HCC Patients

  This clinical trial update notes the completion of a study evaluating R1vascular hepatectomy in patients with hepatocellular carcinoma.

• CLINICAL_TRIALS trial_result · 2018-03-23
  Clinical Trial Update: Evaluation of Remnant Liver Function Using Primovist-enhanced MRI Before Resection/Ablation of Hepatocellular Carcinoma

  This completed clinical trial evaluated remnant liver function using Primovist-enhanced MRI before resection or ablation of hepatocellular c…

• CLINICAL_TRIALS trial_result · 2018-03-16
  Clinical Trial Update: HAIC of FOLFOX vs. HAIC of OXA for Advanced HCC [Phase 3]

  Phase 3 clinical trial comparing hepatic arterial infusion chemotherapy with FOLFOX versus oxaliplatin (OXA) for advanced hepatocellular car…

• CLINICAL_TRIALS research · 2018-03-16
  Clinical Trial Update: An Open-label Phase I/II Clinical Trial of PT-112 Injection for Advanced Solid Tumors and Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]

  Open-label Phase 1/2 trial of PT-112 Injection in patients with advanced solid tumors and advanced hepatocellular carcinoma.

• CLINICAL_TRIALS research · 2018-03-09
  Clinical Trial Update: Diagnostic Value of AFP-L3 and PIVKA-II in HCC

  Clinical trial evaluating the diagnostic value of AFP-L3 and PIVKA-II biomarkers for hepatocellular carcinoma.

• CLINICAL_TRIALS research · 2018-02-26
  Clinical Trial Update: Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric Cancer [Phase 1, Phase 2]

  Exploratory Phase 1/2 clinical study evaluating apatinib plus SHR-1210 in advanced gastric cancer or hepatocellular carcinoma; status is unk…

• CLINICAL_TRIALS withdrawal · 2018-02-26
  Clinical Trial Update: Intervention Protocol for Automated Point-of-Care Surveillance of Outpatient Delays in Cancer Diagnosis [NA]

  Clinical trial NCT01710293, sponsored by the VA Office of Research and Development, has been withdrawn. The study evaluated an intervention …

• CLINICAL_TRIALS trial_result · 2018-02-14
  Clinical Trial Update: Sorafenib in Liver Function Impaired Advanced Hepatocellular Carcinoma [Phase 2, Phase 3]

  Clinical trial update for sorafenib in liver function-impaired advanced hepatocellular carcinoma across Phase 2 and Phase 3 completed.